Our research identifies emerging hotspots in mitochondrial-related tumor immunology, focusing on apoptosis activation, cell cycle regulation, and cutting-edge nanotechnologies such as “tumor necrosis factor”. The gene discussed is TNF; the disease is neoplasm.